109 related articles for article (PubMed ID: 30517020)
1. Cost associated with hematopoietic stem cell transplantation: a retrospective claims data analysis in Germany.
Mayerhoff L; Lehne M; Hickstein L; Salimullah T; Prieur S; Thomas SK; Zhang J
J Comp Eff Res; 2019 Jan; 8(2):121-131. PubMed ID: 30517020
[TBL] [Abstract][Full Text] [Related]
2. Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
Tada K; Kim SW; Asakura Y; Hiramoto N; Yakushijin K; Kurosawa S; Tajima K; Mori S; Heike Y; Tanosaki R; Maeshima AM; Taniguchi H; Furuta K; Kagami Y; Matsuno Y; Tobinai K; Takaue Y; Fukuda T
Am J Hematol; 2012 Aug; 87(8):770-5. PubMed ID: 22641292
[TBL] [Abstract][Full Text] [Related]
3. Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA.
Ren J; Asche CV; Shou Y; Galaznik A
J Comp Eff Res; 2019 Apr; 8(6):393-402. PubMed ID: 30855175
[TBL] [Abstract][Full Text] [Related]
4. Economic burden following allogeneic hematopoietic stem cell transplant in patients with diffuse large B-cell lymphoma.
Maziarz RT; Hao Y; Guerin A; Gauthier G; Gauthier-Loiselle M; Thomas SK; Eldjerou L
Leuk Lymphoma; 2018 May; 59(5):1133-1142. PubMed ID: 28933643
[TBL] [Abstract][Full Text] [Related]
5. Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USA.
Morrison VA; Bell JA; Hamilton L; Ogbonnaya A; Shih HC; Hennenfent K; Eaddy M; Shou Y; Galaznik A
Future Oncol; 2018 Oct; 14(25):2627-2642. PubMed ID: 29911900
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.
Hamadani M; Awan FT; Elder P; Lin TS; Porcu P; Benson DM; Blum KA; Devine SM
Leuk Lymphoma; 2008 Oct; 49(10):1893-8. PubMed ID: 18949613
[TBL] [Abstract][Full Text] [Related]
7. High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.
Hamadani M; Benson DM; Lin TS; Porcu P; Blum KA; Devine SM
Eur J Haematol; 2008 Dec; 81(6):425-31. PubMed ID: 18774954
[TBL] [Abstract][Full Text] [Related]
8. Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients.
Yoon JH; Kim JW; Jeon YW; Lee SE; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Park CW; Cho SG
Korean J Intern Med; 2015 May; 30(3):362-71. PubMed ID: 25995667
[TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic cell transplantation for diffuse large B-cell and follicular lymphoma: Current controversies and advances.
Epperla N; Hamadani M
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):277-284. PubMed ID: 28633038
[TBL] [Abstract][Full Text] [Related]
11. Impact of event-free survival status after stem cell transplantation on subsequent survival of patients with lymphoma.
Fujimoto A; Anzai T; Fukuda T; Uchida N; Ohta T; Mori T; Sawa M; Yoshioka S; Miyamoto T; Uchiyama H; Katayama Y; Matsuoka KI; Shiratori S; Nakazawa H; Kanda J; Ichinohe T; Atsuta Y; Fujita N; Kondo E; Suzuki R
Blood Adv; 2021 Mar; 5(5):1412-1424. PubMed ID: 33666656
[TBL] [Abstract][Full Text] [Related]
12. Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced-intensity and myeloablative conditioning.
Suh KJ; Kim I; Lim J; Ha H; Park S; Koh Y; Yoon SS; Park S
Clin Transplant; 2015 Feb; 29(2):124-33. PubMed ID: 25430486
[TBL] [Abstract][Full Text] [Related]
13. Cost structure and clinical outcome of a stem cell transplantation program in a developing country: the experience in northeast Mexico.
Jaime-Pérez JC; Heredia-Salazar AC; Cantú-Rodríguez OG; Gutiérrez-Aguirre H; Villarreal-Villarreal CD; Mancías-Guerra C; Herrera-Garza JL; Gómez-Almaguer D
Oncologist; 2015 Apr; 20(4):386-92. PubMed ID: 25746343
[TBL] [Abstract][Full Text] [Related]
14. Changing role of stem cell transplantation in follicular lymphoma.
Laport GG
Hematology Am Soc Hematol Educ Program; 2012; 2012():417-25. PubMed ID: 23233613
[TBL] [Abstract][Full Text] [Related]
15. [Autologous hematopoietic stem cell transplantation for patients with diffuse large B-cell lymphoma: a retrospective study].
Lu XL; Li Y; Huang WR; Guo YL; Zhao XL; Lu N; Zhu HY; Wang QS; Yu L; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):617-22. PubMed ID: 23815909
[TBL] [Abstract][Full Text] [Related]
16. Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France.
Mounié M; Costa N; Conte C; Petiot D; Fabre D; Despas F; Lapeyre-Mestre M; Laurent G; Savy N; Molinier L
J Med Econ; 2020 Mar; 23(3):235-242. PubMed ID: 31876205
[No Abstract] [Full Text] [Related]
17. Standard R-CHOP therapy in follicular lymphoma and diffuse large B-cell lymphoma.
Tomita N; Takasaki H; Fujisawa S; Miyashita K; Ogusa E; Kishimoto K; Matsuura S; Sakai R; Koharazawa H; Yamamoto W; Fujimaki K; Fujita H; Ishii Y; Taguchi J; Kuwabara H; Motomura S; Ishigatsubo Y
J Clin Exp Hematop; 2013; 53(2):121-5. PubMed ID: 23995108
[TBL] [Abstract][Full Text] [Related]
18. Cost analysis of autologous peripheral stem cell transplantation versus autologous bone marrow transplantation for patients with non Hodgkin's lymphoma and acute lymphoblastic leukaemia.
Jerjis S; Croockewit S; Muus P; Schaap N; Preijers F; de Witte T
Leuk Lymphoma; 1999 Dec; 36(1-2):33-43. PubMed ID: 10613448
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of reduced-intensity allogeneic hematopoietic stem cell transplantation for refractory or relapsed follicular lymphoma.
Ono Y; Mori T; Kato J; Yamane A; Shimizu T; Kikuchi T; Kohashi S; Okamoto S
Am J Hematol; 2012 Sep; 87(9):929-31. PubMed ID: 22674621
[TBL] [Abstract][Full Text] [Related]
20. Longer intervals between hematopoietic stem cell transplantation and subsequent 90Y-ibritumomab radioimmunotherapy may correlate with better tolerance.
Buchegger F; Prior JO; Allenbach G; Baechler S; Kosinski M; Helg C; Chalandon Y; Ratib O; Delaloye AB; Ketterer N
Clin Nucl Med; 2012 Oct; 37(10):960-4. PubMed ID: 22955069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
